The Journal of Organic Chemistry
ARTICLE
as a viscous liquid. [R]25D ꢀ66.1 (c 1.02, CHCl3). FTIR (ATR) ν 2960,
mmol) with L-Selectride (5.25 mL, 5.25 mmol, 1.0 M in THF) afforded
1
1735, 1491, 1366, 1174, 1073, 1014, 824 cmꢀ1. H NMR (500 MHz,
R-amino acid 5g (0.96 g, 88%) as a viscous liquid. [R]25D ꢀ60.2 (c 1.04,
CDCl3) δ (ppm) 1.20 (t, J = 7.25 Hz, 3 H), 1.23 (s, 9 H), 4.06ꢀ4.28 (m,
2 H), 4.62 (d, J = 4.10 Hz) 1 H), 5.04 (d, J = 4.10 Hz, 1 H), 7.27ꢀ7.37
(m, 4 H). 13C NMR (125 MHz, CDCl3) δ (ppm) 13.9, 22.5, 55.9, 59.7,
62.3, 128.6, 129.1, 134.3, 135.8, 170.8. HRMS (EI) calcd for
C14H21NO3SCl [M þ H] 318.0931, found 318.0928.
CDCl3). FTIR (ATR) ν 2981, 1733, 1286, 1194, 1131, 1053, 853 cmꢀ1
.
1H NMR (500 MHz, CDCl3) δ (ppm) 1.24 (s, 9 H), 1.27ꢀ1.32 (m,
3 H), 1.41 (d, J = 6.94 Hz, 3 H), 3.96ꢀ4.06 (m, 1 H), 4.16 (br s, 1 H),
4.22 (q, J = 7.25 Hz, 2 H). 13C NMR (125 MHz, CDCl3) δ (ppm) 14.1,
19.7, 22.5, 52.6, 55.7, 61.7, 173.4. HRMS (EI) calcd for C9H20NO3S [M
þ H] 222.1164, found 222.1156.
(R)-Ethyl 2-(2,5-difluorophenyl)-2-[(R)-1,1-dimethylethyl-
sulfinamido]acetate, 5c: Following the general procedure (GP2),
the reaction of (R,E)-ethyl 2-[(tert-butylsulfinyl)imino]-2-(2,5-fluoro-
phenyl)acetate (4c) (1.58 g, 5.0 mmol) with L-Selectride (5.25 mL, 5.25
mmol, 1.0 M in THF) afforded R-amino acid 5c (1.35 g, 85%) as a
(R)-Ethyl 2-[(R)-1,1-dimethylethylsulfinamido]-3-methyl-
butanoate, 5h: Following the general procedure (GP2), the reaction
of (R,E)-ethyl 2-[(tert-butylsulfinyl)imino]-3-methylbutanoate (4h)
(1.2 g, 5.0 mmol) with L-Selectride (5.25 mL, 5.25 mmol, 1.0 M in
viscous liquid. [R]25 ꢀ86.4 (c 1.12, CHCl3). FTIR (ATR) ν 2981,
THF) afforded R-amino acid 5h (1.07 g, 86%) as a viscous liquid. [R]25
D
D
1
1736, 1624, 1598, 1459, 1183, 1119, 1071, 849, 673 cmꢀ1. H NMR
ꢀ100.8 (c 0.98, CDCl3). FTIR (ATR) ν 2969, 1732, 1467, 1198, 1064,
724 cmꢀ1. 1H NMR (500 MHz, CDCl3) δ (ppm) 0.90 (d, J = 6.94 Hz,
3 H), 0.97 (d, J = 6.94 Hz, 3 H), 1.27 (s, 9 H), 1.29 (t, J = 7.09 Hz, 3 H),
2.00ꢀ2.18 (m, 1 H), 3.71 (dd, J = 7.88, 5.04 Hz, 1 H), 4.10 (d, J = 7.88
Hz, 1 H), 4.15ꢀ4.29 (m, 2 H). 13C NMR (125 MHz, CDCl3) δ
ppm 14.1, 17.3, 19.1, 22.7, 32.3, 56.2, 61.5, 63.1, 173.0. HRMS (EI) calcd
for C11H24NO3S [M þ H] 250.1477, found 250.1479.
(500 MHz, CDCl3) δ (ppm) 1.23 (t, J = 7.09 Hz, 3 H), 1.27 (s, 9 H),
4.11ꢀ4.29 (m, 2 H), 4.60 (d, J = 3.78 Hz, 1 H), 5.03 (d, J = 4.10 Hz, 1
H), 6.72ꢀ6.81 (m, 1 H), 6.94 (d, J = 5.67 Hz, 2 H). 13C NMR (125
MHz, CDCl3) δ (ppm) 13.9, 22.5, 56.2, 59.5, 62.7, 103.9, (t, J = 25.20
Hz) 104.1, 110.6, 110.6, 141.0, 162.0 (d, J = 11.91 Hz), 164.0 (d, J =
12.81 Hz), 170.2. HRMS (EI) calcd for C14H20NO3SF2 [M þ H]
320.1132, found 320.1125.
(R)-Ethyl 2-[(R)-1,1-dimethylethylsulfinamido]icosanoate, 5i:
Following the general procedure (GP2), the reaction of (R,E)-ethyl
2-[(tert-butylsulfinyl)imino]icosanoate (4i) (2.28 g, 5.0 mmol) with L-
Selectride (5.25 mL, 5.25 mmol, 1.0 M in THF) afforded R-amino acid
(R)-Ethyl 2-(4-methoxyphenyl)-2-[(R)-1,1-dimethylethyl-
sulfinamido]actate, 5d: Following the general procedure (GP2),
the reaction of (R,E)-ethyl 2-[(tert-butylsulfinyl)imino]-2-(4-methoxy-
phenyl)acetate (4d) (1.55 g, 5.0 mmol) with L-Selectride (5.25 mL, 5.25
mmol, 1.0 M in THF) afforded R-amino acid 5d (1.34 g, 86%) as a
viscous liquid. [R]25D ꢀ161.1 (c 1., CHCl3). FTIR (ATR) ν 2959, 1733,
5i (2.15 g, 94%) as a viscous liquid. [R]25 ꢀ134.2 (c 1.14, CHCl3).
D
FTIR (ATR) ν 2915, 2850, 1740, 1470, 1180, 1072, 716 cmꢀ1. 1H NMR
(500 MHz, CDCl3) δ (ppm) 0.88 (t, J = 6.94 Hz, 3 H), 1.12ꢀ1.45 (m,
44 H), 1.62ꢀ1.86 (m, 2 H), 3.84ꢀ3.95 (m, 1 H), 4.08 (d, J = 7.25 Hz,
1 H), 4.22 (q, J = 7.25 Hz, 2 H). 13C NMR (125 MHz, CDCl3) δ (ppm)
14.1, 22.6, 24.9, 29.1, 29.3, 29.6, 29.7, 31.9, 33.9, 55.9, 57.4, 61.5, 173.4.
HRMS (EI) calcd for C26H54NO3S [M þ H] 460.3824, found
460.3820.
1
1512, 1245, 1175, 1071, 831 cmꢀ1. H NMR (500 MHz, CDCl3) δ
(ppm) 1.20 (t, J = 7.09 Hz, 3 H), 1.23 (s, 9 H), 3.81 (s, 3 H), 4.04ꢀ4.30
(m, 2 H), 4.54 (d, J = 3.78 Hz, 1 H), 5.01 (d, J = 4.10 Hz, 1 H), 6.88 (d,
J = 8.83 Hz, 2 H), 7.28 (d, J = 8.83 Hz, 2 H). 13C NMR (125 MHz,
CDCl3) δ (ppm) 13.9, 22.5, 55.2, 55.8, 59.8, 62.0, 114.0, 128.9, 129.2,
159.8, 171.5. HRMS (EI) calcd for C15H24NO4S [M þ H] 314.1426,
found 314.1420.
(R)-Ethyl 2-(1,2-dihydroacenaphthylen-5-yl)-2-[(R)-1,1-
dimethylethylsulfinamido]acetate 5j. Following the general
procedure (GP2), the reaction of (R,E)-ethyl 2-[(tert-butylsulfinyl)
imino]-(1,2-dihydroacenaphthylen-5-yl)acetate (4j) (1.75 g, 5.0 mmol)
with L-Selectride (5.25 mL, 5.25 mmol, 1.0 M in THF) afforded
(R)-Ethyl 2-(4-tert-butylphenyl)-2-[(R)-1,1-dimethylethyl-
sulfinamido]acetate, 5e: Following the general procedure (GP2),
the reaction of (R,E)-ethyl 2-[(tert-butylsulfinyl)imino]-2-(4-tert-butyl-
phenyl)acetate (4e) (1.68 g, 5.0 mmol) with L-Selectride (5.25 mL, 5.25
mmol, 1.0 M in THF) afforded R-amino acid 5e (1.52 g, 90%) as a
R-amino acid 5j (1.61 g, 90%) as a viscous liquid. [R]25 ꢀ124.8
D
(c 1.10, CHCl3). FTIR (ATR) ν 2959, 1729, 1215, 1178, 1068,
viscous liquid. [R]25 ꢀ145.9 (c 0.98, CHCl3). FTIR (ATR) ν 2959,
838 cmꢀ1. H NMR (500 MHz, CDCl3) δ (ppm) 1.10 (t, J = 7.09
1
D
299, 1735, 1246, 1175, 1074, 849 cmꢀ1. 1H NMR (500 MHz, CDCl3) δ
(ppm) 1.22 (t, J = 7.09 Hz, 3 H), 1.24 (s, 9 H), 1.30ꢀ1.32 (m, 9 H),
4.07ꢀ4.17 (m, 1 H), 4.24 (dd, J = 10.72, 7.25 Hz, 1 H), 4.56 (d, J = 5.04
Hz, 1 H), 5.03 (d, J = 5.04 Hz, 1 H), 7.26ꢀ7.31 (m, 2 H), 7.33ꢀ7.39 (m,
2 H). 13C NMR (125 MHz, CDCl3) δ (ppm) 13.9, 22.5, 31.2, 34.5, 55.9,
60.2, 62.0, 125.5, 127.1, 134.1, 151.2, 171.5. HRMS (EI) calcd for
C18H30NO3S [M þ H] 340.1946, found 340.1941.
Hz, 3 H), 1.15 (s, 9 H), 3.27ꢀ3.43 (m, 4 H), 4.08 (dd, J = 10.88, 7.09 Hz,
1 H), 4.21 (dd, J = 10.88, 7.09 Hz, 1 H), 4.71 (d, J = 3.47 Hz, 1 H), 5.56
(d, J = 3.78 Hz, 1 H), 7.25 (dd, J = 21.75, 6.94 Hz, 2 H), 7.40ꢀ7.50 (m, 2
H), 7.76 (d, J = 8.51 Hz, 1 H). 13C NMR (125 MHz, CDCl3) δ (ppm)
13.9, 22.5, 30.0, 30.5, 55.7, 58.5, 62.1, 118.7, 119.5, 128.1, 129.5, 138.8,
146.4, 147.3, 172.0. HRMS (EI) calcd for C20H26NO3S [M þ H]
360.1633, found 360.1630.
(R)-Ethyl 2-(4-butylphenyl)-2-[(R)-1,1-dimethylethylsulfi-
namido]acetate, 5f: Following the general procedure (GP2), the
reaction of (R,E)-ethyl 2-[(tert-butylsulfinyl)imino]-2-(4-butylphe-
nyl)acetate (4f) (1.66 g, 5.0 mmol) with L-Selectride (5.25 mL, 5.25
mmol, 1.0 M in THF) afforded R-amino acid 5f (1.50 g, 89%) as a
(R)-Ethyl 2-(phenanthren-9-yl)-2-[(R)-1,1-dimethylethyl-
sulfinamido]acetate 5k. Following the general procedure (GP2),
the reaction of (R,E)-ethyl 2-[(tert-butylsulfinyl)imino]-2-(phenanthren-
9-yl)acetate (4k) (1.90 g, 5.0 mmol) with L-Selectride (5.25 mL, 5.25
mmol, 1.0 M in THF) afforded R-amino acid 5k (1.74 g, 91%) as a
viscous liquid. [R]25 ꢀ128.2 (c 1.16, CDCl3). FTIR (ATR) ν 2960,
viscous liquid. [R]25 ꢀ134.4 (c 1.19, CHCl3). FTIR (ATR) ν 2959,
D
D
1734, 1249, 1174, 1077, 1018, 825 cmꢀ1. 1H NMR (500 MHz, CDCl3)
δ (ppm) 0.92 (t, J = 7.41 Hz, 3 H), 1.20 (t, J = 7.09 Hz, 3 H), 1.23 (s,
9 H), 1.32ꢀ1.41 (m, 2 H), 1.50ꢀ1.64 (m, 2 H), 2.54ꢀ2.64 (m, 2 H),
4.07ꢀ4.17 (m, 1 H), 4.17ꢀ4.28 (m, 1 H), 4.58 (d, J = 4.73 Hz, 1 H),
5.02 (d, J = 4.73 Hz, 1 H), 7.15 (d, J = 8.20 Hz, 2 H), 7.26 (d, J = 7.88 Hz,
2 H). 13C NMR (125 MHz, CDCl3) δ (ppm) 13.9, 22.3, 22.5, 33.3, 35.2,
55.9, 60.3, 62.0, 127.4, 128.6, 134.4, 143.1, 171.5. HRMS (EI) calcd for
C18H30NO3S [M þ H] 340.1930, found 340.1921.
1728, 1219, 1115, 1068, 728 cmꢀ1. H NMR (500 MHz, CDCl3) δ
1
(ppm) 1.04 (t, J = 7.09 Hz, 3 H), 1.12 (s, 9 H), 4.05ꢀ4.23 (m, 2 H), 5.64
(d, J = 3.15 Hz, 1 H), 7.50ꢀ7.65 (m, 4 H), 7.82 (s, 1 H), 7.86 (d, J = 7.57
Hz, 1 H), 8.09ꢀ8.16 (m, 1 H), 8.60 (d, J = 8.20 Hz, 1 H), 8.67 (d, J =
7.88 Hz, 1 H). 13C NMR (125 MHz, CDCl3) δ (ppm) 13.9, 22.5, 55.7,
60.0, 62.3, 122.5, 123.3, 124.8, 126.6, 126.9, 127.4, 128.9, 129.6, 130.7,
130.7, 131.0, 131.2, 171.9. HRMS (EI) calcd for C22H26NO3S [M þ H]
384.1633, found 384.1638.
(S)-Ethyl 2-[(S)-1,1-dimethylethylsulfinamido]-2-phenyla-
cetate, ent-5a: Following the general procedure (GP2), the reaction
of (S,E)-ethyl 2-[(tert-butylsulfinyl)imino]-2-phenylacetate (ent-4a)
(R)-Ethyl 2-[(R)-1,1-dimethylethylsulfinamido]propano-
ate, 5g: Following the general procedure (GP2), the reaction of
(R,E)-ethyl 2-[(tert-butylsulfinyl)imino]propanoate (4g) (1.1 g, 5.0
3413
dx.doi.org/10.1021/jo200401a |J. Org. Chem. 2011, 76, 3409–3415